Hsa-microRNA-27b-3p inhibits hepatocellular carcinoma progression by inactivating transforming growth factor-activated kinase-binding protein 3/nuclear factor kappa B signalling.
Jingyuan WenZhao HuangYi WeiLin XueYufei WangJingyu LiaoJunnan LiangXiaoping ChenLiang ChuBixiang ZhangPublished in: Cellular & molecular biology letters (2022)
By targeting TAB3, hsa-miR-27b acted as a tumour suppressor by inactivating the NF-кB pathway in HCC in vitro and in vivo, indicating its therapeutic value against HCC.